Ronifibrate is a fibrate class lipid-modifying agent primarily utilized to treat hyperlipidemia by lowering triglyceride levels and increasing high-density lipoprotein cholesterol. This compound functions… Read more
Ronifibrate is a fibrate class lipid-modifying agent primarily utilized to treat hyperlipidemia by lowering triglyceride levels and increasing high-density lipoprotein cholesterol. This compound functions by activating peroxisome proliferator-activated receptors (PPARs) to enhance fatty acid oxidation and reduce hepatic VLDL synthesis. Analytical laboratories require high-quality reference standards for Ronifibrate, alongside its related pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds, to ensure rigorous quality control and accurate results. These specialized materials are essential for conducting precise impurity profiling and validating analytical methods such as HPLC or LC-MS/MS during drug development and regulatory testing. By providing reliable benchmarks for identification and quantification, these compounds support the maintenance of therapeutic safety and efficacy throughout the pharmaceutical manufacturing process.